Subscribe To
U.s. ipo weekly recap: the february ipo market kicks off with 2 biotechs
U.S. IPO Weekly Recap: The February IPO Market Kicks Off With 2 Biotechs...
February 5, 2022, 12:15 am
Immunovant: speculative biotech with proven class of drugs targeting fcrn pathway
Immunovant: Speculative biotech With Proven Class Of Drugs Targeting FcRn Pathway...
February 4, 2022, 10:01 pm
Immunovant: speculative biotech with proven class of drugs targeting fcrn pathway
Immunovant: Speculative biotech With Proven Class Of Drugs Targeting FcRn Pathway...
February 4, 2022, 10:01 pm
Immunovant: speculative biotech with proven class of drugs targeting fcrn pathway
Immunovant: Speculative biotech With Proven Class Of Drugs Targeting FcRn Pathway...
February 4, 2022, 10:01 pm
Waters corporation ceo discusses the importance of its data reporting software and state of biotech
Udit Batra, CEO and president of Waters Corporation, appeared on Friday's episode of "Mad Money."...
February 4, 2022, 8:01 pm
Waters corporation ceo discusses the importance of its data reporting software and state of biotech
Udit Batra, CEO and president of Waters Corporation, appeared on Friday's episode of "Mad Money."...
February 4, 2022, 8:01 pm
Waters corporation ceo discusses the importance of its data reporting software and state of biotech
Udit Batra, CEO and president of Waters Corporation, appeared on Friday's episode of "Mad Money."...
February 4, 2022, 8:01 pm
5 biotech stocks to buy to benefit from biden's new cancer cabinet
Joe Biden is redoubling his efforts to fight cancer with a new "cancer cabinet." Here are the biotech s...
February 4, 2022, 11:36 am
5 biotech stocks to buy to benefit from biden's new cancer cabinet
Joe Biden is redoubling his efforts to fight cancer with a new "cancer cabinet." Here are the biotech s...
February 4, 2022, 11:36 am
5 biotech stocks to buy to benefit from biden's new cancer cabinet
Joe Biden is redoubling his efforts to fight cancer with a new "cancer cabinet." Here are the biotech s...
February 4, 2022, 11:36 am
Imugene tagged a "buy" by roth capital partners after securing roche clinical supply deal and patents in europe and japan
Imugene Ltd (ASX:IMU, OTC:IUGNF)'s recent clinical and patent activities have drawn the attention of Roth Capital Partners, which has placed a “buy�...
February 3, 2022, 8:03 pm
Imugene tagged a "buy" by roth capital partners after securing roche clinical supply deal and patents in europe and japan
Imugene Ltd (ASX:IMU, OTC:IUGNF)'s recent clinical and patent activities have drawn the attention of Roth Capital Partners, which has placed a “buy�...
February 3, 2022, 8:03 pm
Imugene tagged a "buy" by roth capital partners after securing roche clinical supply deal and patents in europe and japan
Imugene Ltd (ASX:IMU, OTC:IUGNF)'s recent clinical and patent activities have drawn the attention of Roth Capital Partners, which has placed a “buy�...
February 3, 2022, 8:03 pm
Psychedelics biotech startup launches phase 1 study on ayahuasca's active ingredient
Psychedelics biotech startup Entheon Biomedical ENBI ENTBF announced the approval by the local Dutch et...
February 3, 2022, 1:53 pm
Psychedelics biotech startup launches phase 1 study on ayahuasca's active ingredient
Psychedelics biotech startup Entheon Biomedical ENBI ENTBF announced the approval by the local Dutch et...
February 3, 2022, 1:53 pm
Psychedelics biotech startup launches phase 1 study on ayahuasca's active ingredient
Psychedelics biotech startup Entheon Biomedical ENBI ENTBF announced the approval by the local Dutch et...
February 3, 2022, 1:53 pm
Janssen inks over $1b pact for mersana's adc technology in three targets
Mersana Therapeutics Inc MRSN has announced a research collaboration and license agreement with Janssen bi...
February 3, 2022, 1:39 pm
Janssen inks over $1b pact for mersana's adc technology in three targets
Mersana Therapeutics Inc MRSN has announced a research collaboration and license agreement with Janssen bi...
February 3, 2022, 1:39 pm
Janssen inks over $1b pact for mersana's adc technology in three targets
Mersana Therapeutics Inc MRSN has announced a research collaboration and license agreement with Janssen bi...
February 3, 2022, 1:39 pm
Drug/biotech stock q4 earnings due on feb 4: bmy, regn & sny
Let us take a look at three biotech/pharma companies ??? BMY, REGN and SNY?...
February 3, 2022, 9:59 am